ZYNERBA PHARMACEUTICALS INC (ZYNE) Stock Balance Sheet
NASDAQ:ZYNE - Nasdaq - US98986X1090 - Common Stock - Currency: USD
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.97M | 50.64M | 67.81M | 59.16M | 70.06M | |||
| Receivables | 1.31M | 1.23M | 9.58M | 9.04M | 14.61M | |||
| Other Current Assets | 2.02M | 2.91M | 2.83M | 5.17M | 2.38M | |||
| Total Current Assets | 39.29M | 54.78M | 80.22M | 73.37M | 87.06M | |||
| Non-Current Assets | ||||||||
| PPE Net | 613.94K | 745.79K | 951.65K | 690.00K | 710.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.18M | 745.78K | 951.65K | 690.00K | 700.00K | |||
| TOTAL ASSETS | 40.48M | 55.52M | 81.17M | 74.06M | 87.76M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.98M | 7.23M | 8.11M | 11.39M | 7.32M | |||
| Accounts Payable | 2.48M | 1.94M | 1.80M | 2.52M | 4.74M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 11.46M | 9.17M | 9.90M | 13.91M | 12.06M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 119.52K | 353.69K | 0.00 | 110.00K | |||
| Total Non-Current Liabilities | 0.00 | 119.53K | 353.69K | 0.00 | 110.00K | |||
| TOTAL LIABILITIES | 11.46M | 9.29M | 10.26M | 13.91M | 12.17M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -295.41M | -274.52M | -239.48M | -202.17M | -150.84M | |||
| Additional Paid In Capital | 324.37M | 320.70M | 310.35M | 262.29M | 226.41M | |||
| Common Shares | 53.94K | 47.90K | 41.22K | 30.00K | 20.00K | |||
| Shares Outstanding | 53.94M | 47.90M | 41.22M | 29.98M | 23.21M | |||
| Tangible Book Value per Share | 0.54 | 0.97 | 1.72 | 2.01 | 3.26 | |||
| Total Shareholders' Equity | 29.02M | 46.23M | 70.91M | 60.14M | 75.60M | |||
| TOTAL LIABILITIES AND EQUITY | 40.48M | 55.52M | 81.17M | 74.06M | 87.76M | |||
| Statistics | ||||||||
| Current Ratio | 3.43 | 5.97 | 8.10 | 5.27 | 7.22 | |||
| Return On Assets (ROA) | -92.85% | -63.10% | -45.96% | -69.32% | -37.53% | |||
| Return On Equity (ROE) | -129.50% | -75.79% | -52.61% | -85.37% | -43.57% | |||
All data in USD , ROIC based on taxRate of 0.21